ExoVasc® PEARS

Exstent wins MasterControl’s award for Digital Transformation in Manufacturing in Lisbon

Since February 2022, Exstent has been employing the MasterControl electronic Quality Management System software to manage its quality documentation and for completing its device history records. The implementation of this system has had a significant impact on Exstent being able to demonstrate control of its systems to external auditors, leading to Exstent achieving its ISO13485:2016 and MDSAP registration.

Gina Phillips, Exstent’s QARA Controller, collected the award on behalf of Exstent at the 2023 MasterControl Conference in Lisbon.

200th patient receives innovative Ross-PEARS implant

Sunday Times article discussing Nick Isiekwe’s ExoVasc® PEARS surgery

Interested in our patient experiences?

We develop medical devices that manage aortic dilation and minimise the risk of aortic dissection.

quick links

statements & policies

Our contact details

The staff of Exstent Limited are not medically qualified and are thus not able to provide clinical advice or answer questions of a clinical nature. We may direct your attention to publications in peer-reviewed journals that provide clinical information or provide information based upon personal experience. However, for any questions of a clinical nature patients are recommended to consult a qualified clinician.